TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 3 | 1 | 7 | 30 | 0 | -27 | 31 | 7 |
| P | %wins | 100 | 67 | 67 | 67 | 0 | 33 | 56 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/20/11 16:30 | 5/18/11 | RNN | Rexahn Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ahn Chang Ho | MD | DOT | CB,CEO | P | 1,321 | 1.31 | 1 | 1,008 | 9 | 11,839 | D | 0 | 6 | 21 | -27 | 2 | 4 | -9 | -1 | 1 | -1 | 0 | -21 | -58 | -67 |
4/5/11 17:00 | 4/1/11 | RNN | Rexahn Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ahn Chang Ho | MD | DOT | CB,CEO | P | 391 | 1.22 | 2 | 321 | 3 | 10,831 | D | 68 | -34 | 3 | 5 | -23 | -16 | -14 | 7 | 3 | 2 | -3 | 6 | -18 | -57 |
5/4/09 17:14 | 5/4/09 | RNN | Rexahn Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ahn Chang Ho | MD | DOT | CB,CEO | P | 177 | 0.6800 | 0 | 260 | 2 | 11,020 | D | -69 | -73 | -29 | -3 | 17 | -9 | -7 | -6 | 0 | 21 | 94 | 16 | -6 | 216 |
4/15/08 12:57 | 4/14/08 | RXHN | Rexahn Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ahn Chang Ho | MD | DOT | CB,CEO | P | 24 | 2.40 | 0 | 10 | 0 | 14,010 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |